In a contrast to its inaugural year, the 2014 Society of Young Adult Oncology (SAYAO) Conference focused entirely on a specific type of cancer: acute lymphoblastic leukemia. Instead of again focusing on general psychosocial aspects of cancer treatments in the adolescent and young adult (AYA) population, this year’s approach allowed attendees to explore survivorship disparities between […]
Dr. Leonard Sender
World’s First “Infusionarium” Comes to CHOC
Any parent who’s ever tried to get the attention of a child engrossed in a video game or movie can certainly appreciate the concept. Our new, multi-screen “Infusionarium” is an innovative video experience offering a welcome distraction for young patients undergoing treatments that often last for hours. The CHOC Infusionarium is the first program of […]
Dr. Leonard Sender Discusses Genomic Cancer Research
Genomic cancer treatment examines a patient’s genomes to reveal individualized treatment to best battle cancer, Dr. Leonard Sender, medical director of the Hyundai Cancer Institute at CHOC, tells “American Health Journal.” Using this method, scientists for the first time can devise science-directed medicine, rather than evidence-based medicine, Dr. Sender says. Learn more about genomic cancer […]
CHOC’s AYA Cancer Efforts Earn National Attention
The adolescent and young adult cancer movement has helped define patients by age rather than disease and raise awareness of the population’s unique needs, Dr. Leonard Sender, medical director of the Hyundai Cancer Institute at CHOC, tells “The Huffington Post.” Dr. Sender’s and CHOC’s leadership role in the adolescent and young adult cancer movement were […]
First Annual Society of Adolescent and Young Adult Oncology Conference Emphasizes Unique Needs of Underserved Patient Population
CHOC recently partnered with the Society of Adolescent and Young Adult Oncology (SAYAO) to host the first-ever national conference for healthcare professionals who are focused on improving care and outcomes for patients between the ages of 15-39. “While survival rates for pediatric cancer have increased dramatically, survival rates for adolescents and young adults (AYA) with cancer […]
